Nicholls SJ, Bhatt DL, Buse JB, Prato SD, et al. Comparison of Tirzepatide and Dulaglutide on Major Adverse Cardiovascular Events in Participants with Type 2 Diabetes and Atherosclerotic Cardiovascular Disease: SURPASS-CVOT Design and Baseline Characteristics. Am Heart J 2023 Sep 25:S0002-8703(23)00280-6. doi: 10.1016/j.ahj.2023.
PMID: 37758044